The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 300, 113860
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major DepressionBiological Psychiatry, 2013
- Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scaleInternational Clinical Psychopharmacology, 2011
- Factors Associated with Work Participation and Work Functioning in Depressed Workers: A Systematic ReviewJournal of Occupational Rehabilitation, 2010
- Work Performance of Employees with Depression: The Impact of Work StressorsAmerican Journal of Health Promotion, 2010
- Presenteeism in the workplace: A review and research agendaJournal of Organizational Behavior, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability ScaleInternational Clinical Psychopharmacology, 2008
- Depression in the Workplace: Costs and Barriers to TreatmentPsychiatric Services, 2001
- Workplace performance effects from chronic depression and its treatmentJournal of Health Economics, 1998
- The measurement of disabilityInternational Clinical Psychopharmacology, 1996